General MedicationsINJECTIONStandard
ANTHIM
OBILTOXAXIMAB
Standard Dose
600MG/6ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview ANTHIM is listed in Drugs@FDA under application 125509 (BLA).
Review priority: STANDARD Marketing status: Prescription Active ingredient OBILTOXAXIMAB Form and strength INJECTABLE;INJECTION - 600MG/6ML Sponsor ELUSYS THERAPEUTICS INC Submission history Latest submission status date: 2019-11-29 00:00:00.
Structured Monograph
Clinical summary
Approval overview ANTHIM is listed in Drugs@FDA under application 125509 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient OBILTOXAXIMAB Form and strength INJECTABLE;INJECTION - 600MG/6ML Sponsor ELUSYS THERAPEUTICS INC Submission history Latest submission status date: 2019-11-29 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.